My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Articles published by Merck KGaA

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

December 22, 2025

From Merck KGaA

Via Business Wire

Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

September 02, 2025

From Merck KGaA

Via Business Wire

Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business

April 28, 2025

From Merck KGaA

Via Business Wire

Merck KGaA, Darmstadt, Germany Provides Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis

December 05, 2023

From Merck KGaA

Via Business Wire

Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib

December 04, 2023

From Merck KGaA

Via Business Wire

Merck KGaA, Darmstadt, Germany, Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate

October 30, 2023

From Merck KGaA

Via Business Wire

Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery

September 20, 2023

From Merck KGaA

Via Business Wire

Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

April 12, 2023

From Merck KGaA

Via Business Wire

Merck KGaA, Darmstadt, Germany Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates

December 22, 2022

From Merck KGaA

Via Business Wire

Merck KGaA, Darmstadt, Germany Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver More Medicines to Patients Faster

November 21, 2022

From Merck KGaA

Via Business Wire

Merck KGaA, Darmstadt, Germany, Announces Changes in Operating Model for Healthcare Business Sector

May 18, 2021

From Merck KGaA

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.